REGISTERED
on 07 May 2024
Last Applicant/ Owned by
3-5-1, Nihonbashi Honcho, Chuo-ku
Tokyo
JP
103-8426
Serial Number
97790414 filed on 10th Feb 2023
Registration Number
7377953 registered on 07th May 2024
Correspondent Address
Molly Hunsinger
Filing Basis
No Filing Basis
Disclaimer
NO DATA
AMLYFEND
Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressive, systemic lupus erythematosus, Netherton syndrome; Vaccines
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressive, systemic lupus erythematosus, Netherton syndrome; Vaccines
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97790414
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 3T23788615
44D Filed
No
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th May 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 07th May 2024 | REGISTERED-PRINCIPAL REGISTER |
| 04th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 20th Feb 2024 | PUBLISHED FOR OPPOSITION |
| 31st Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 31st Jan 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 17th Jan 2024 | ELECTRONIC RECORD REVIEW COMPLETE |
| 29th Dec 2023 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 22nd Dec 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 21st Dec 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |